Bror Thomas Pollare

Dr. Bror Thomas Pollare is a Chairman at AlzeCure Pharma AB, a Chairman at Ac Intressenter AB, a Chairman at Alzecure Discovery AB, a Chairman at Alzecure Foundation, a Chairman at Sinfonia Biotherapeutics AB and a Chairman & Chief Executive Officer at Oncolution AB. He is on the Board of Directors at Carmel Pharma AB, Pharmaceuticals Sales & Development AB, Premalux AB and Psilox AB. Dr. Pollare was previously employed as a Deputy Director by Bio-Works Technologies AB, a Chief Executive Officer by Global Medical Investments GMI AB, a Partner by 3i Nordic Plc, a Partner by 3i Plc, a Chairman by A3P Biomedical AB (publ), a Vice President by Pharmacia Corp., a Chairman by QUIA PHARMA AB, a Chairman by QuiaPEG Pharmaceuticals AB, a Vice President by Schering Plough, Inc., and a Director-Supervisory Board by Trigen Holdings AG.
He also served on the board at SSI Diagnostica A/S, Cereno Scientific AB, Cancun Oncology Center S A P I De C V Mexico, Center Oncologico Y De Radioterapia Tec 100 S A P I De C V, Centro De Neuro Radiocirugia San Javier Gamma Knife SA de CV, Centro Gamma Knife Dominicana SRL, Centro Gamma Knife Santiago Sap, Gamma Knife Center Ecuador SA, Gyros AB, Premacure AB, Premacure Holding AB, PT Gammaknife Center Indonesia, Sweden Ghana Medical Center Ltd. and Xellia Pharmaceuticals ApS.
He received his doctorate degree from Karolinska Institutet and a doctorate degree from the University of Uppsala.